Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs

Details for Australian Patent Application No. 2002323063 (hide)

Owner Entremed, Inc. The Children's Medical Center Corporation

Inventors Conner, Barry P.; Hunsucker, Kimberly A.; Rougas, John; Swartz, Glenn. M. Jr.; Treston, Anthony; Shah, Jamshed H.; D'Amato, Robert; Pribluda, Victor

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002323063

PCT Number PCT/US02/25112

PCT Pub. Number WO2003/014315

Priority 60/310,261 06.08.01 US

Filing date 6 August 2002

Wipo publication date 24 February 2003

Acceptance publication date 8 November 2007

International Classifications

A61K 31/454 (2006.01)

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/02 (2006.01) Drugs for disorders of the senses

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/310,261 06.08.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002323063

8 November 2007 Application Accepted

  Published as AU-B-2002323063

6 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002323064-METHOD FOR MAKING ALUMINA

2002323062-Integral reversing and trim deflector and control mechanism